SEARCH:   Advanced

Blood, 15 July 2007, Vol. 110, No. 2, pp. 695-708. Prepublished online as a Blood First Edition Paper on March 27, 2007; DOI 10.1182/blood-2006-11-051672. This Article Full Text (PDF) Supplemental Tables All Versions of this Article: blood-2006-11-051672v1 110/2/695    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Morton, L. M Articles by Weisenburger, D. D Search for Related Content PubMed PubMed Citation Articles by Morton, L. M Articles by Weisenburger, D. D Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted November 2, 2006 Accepted March 10, 2007 Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph) Lindsay M Morton*, Jennifer J Turner, James R Cerhan, Martha S Linet, Patrick A Treseler, Christina A Clarke, Andrew Jack, Wendy Cozen, Marc Maynadie, John J Spinelli, Adele Seniori Costantini, Thomas Rudiger, Aldo Scarpa, Tongzhang Zheng, and Dennis D Weisenburger Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD, United States Department of Anatomical Pathology, St. Vincent's Hospital, New South Wales, Australia Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States Department of Pathology, University of California at San Francisco, San Francisco, CA, United States Northern California Cancer Center, Fremont, CA, United States Haematological Malignancy Diagnostic Service, Department of Haematology, Leeds Teaching Hospital, NHS Trust, Leeds, United Kingdom Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States Haematology Laboratory, University Hospital, Dijon, France British Columbia Cancer Agency, Vancouver, British Columbia, Canada Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy Institute of Pathology, University of Wurzburg, Wurzburg, Germany Department of Pathology, University of Verona, Ospedale Policlinico, Verona, Italy Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, United States Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States * Corresponding author; email: mortonli{at}mail.nih.gov. Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathological schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases-Oncology, third edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will likely prove to be critical for elucidating etiologies of the various lymphoid neoplasms. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: J. Kanda, K. Matsuo, T. Kawase, T. Suzuki, T. Ichinohe, M. Seto, Y. Morishima, K. Tajima, and H. Tanaka Association of Alcohol Intake and Smoking with Malignant Lymphoma Risk in Japanese: A Hospital-Based Case-Control Study at Aichi Cancer Center Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2436 - 2441. [Abstract] [Full Text] [PDF] C. M. Vajdic, M. O. Falster, S. de Sanjose, O. Martinez-Maza, N. Becker, P. M. Bracci, M. Melbye, K. E. Smedby, E. A. Engels, J. Turner, et al. Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis Cancer Res., August 15, 2009; 69(16): 6482 - 6489. [Abstract] [Full Text] [PDF] Q. Lan, L. M. Morton, B. Armstrong, P. Hartge, I. Menashe, T. Zheng, M. P. Purdue, J. R. Cerhan, Y. Zhang, A. Grulich, et al. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies Blood, July 9, 2009; 114(2): 264 - 267. [Abstract] [Full Text] [PDF] T. H.M. Keegan, L. A. McClure, J. M. Foran, and C. A. Clarke Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study J. Clin. Oncol., June 20, 2009; 27(18): 3044 - 3051. [Abstract] [Full Text] [PDF] P. T. Bradford, S. S. Devesa, W. F. Anderson, and J. R. Toro Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases Blood, May 21, 2009; 113(21): 5064 - 5073. [Abstract] [Full Text] [PDF] L. R. Goldin, M. Bjorkholm, S. Y. Kristinsson, I. Turesson, and O. Landgren Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia Haematologica, May 1, 2009; 94(5): 647 - 653. [Abstract] [Full Text] [PDF] L. M. Morton, M. P. Purdue, T. Zheng, S. S. Wang, B. Armstrong, Y. Zhang, I. Menashe, N. Chatterjee, S. Davis, Q. Lan, et al. Risk of Non-Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1259 - 1270. [Abstract] [Full Text] [PDF] M. P. Purdue, Q. Lan, S. S. Wang, A. Kricker, I. Menashe, T.-Z. Zheng, P. Hartge, A. E. Grulich, Y. Zhang, L. M. Morton, et al. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma Carcinogenesis, February 1, 2009; 30(2): 275 - 281. [Abstract] [Full Text] [PDF] L. M. Morton, S. S. Wang, W. Cozen, M. S. Linet, N. Chatterjee, S. Davis, R. K. Severson, J. S. Colt, M. A. Vasef, N. Rothman, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes Blood, December 15, 2008; 112(13): 5150 - 5160. [Abstract] [Full Text] [PDF] K. L. Edlefsen, A. De Roos, and A. LaCroix Application of the InterLymph Consortium's Proposed Classification of Lymphoid Neoplasms for Epidemiologic Research to a Large, Nationwide Health Study: Experience in the Women's Health Initiative Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 4669 - 4669. [Abstract] Q. Lan, U. Lim, C.-S. Liu, S. J. Weinstein, S. Chanock, M. R. Bonner, J. Virtamo, D. Albanes, and N. Rothman A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma Blood, November 15, 2008; 112(10): 4247 - 4249. [Abstract] [Full Text] [PDF] A. M. Evens and B. C.-H. Chiu The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma JAMA, November 5, 2008; 300(17): 2059 - 2061. [Full Text] [PDF] L. A. Anderson, R. Pfeiffer, J. L. Warren, O. Landgren, S. Gadalla, S. I. Berndt, W. Ricker, R. Parsons, W. Wheeler, and E. A. Engels Hematopoietic Malignancies Associated with Viral and Alcoholic Hepatitis Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3069 - 3075. [Abstract] [Full Text] [PDF] T. M. Habermann, S. S. Wang, M. J. Maurer, L. M. Morton, C. F. Lynch, S. M. Ansell, P. Hartge, R. K. Severson, N. Rothman, S. Davis, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era Blood, October 1, 2008; 112(7): 2694 - 2702. [Abstract] [Full Text] [PDF] A. E. Khan, V. Gallo, J. Linseisen, R. Kaaks, S. Rohrmann, O. Raaschou-Nielsen, A. Tjonneland, H. E. Johnsen, K. Overvad, M. M. Bergmann, et al. Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition Haematologica, June 1, 2008; 93(6): 842 - 850. [Abstract] [Full Text] [PDF] Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al. Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma Am. J. Epidemiol., June 1, 2008; 167(11): 1321 - 1331. [Abstract] [Full Text] [PDF] K. Ekstrom Smedby, C. M. Vajdic, M. Falster, E. A. Engels, O. Martinez-Maza, J. Turner, H. Hjalgrim, P. Vineis, A. Seniori Costantini, P. M. Bracci, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium Blood, April 15, 2008; 111(8): 4029 - 4038. [Abstract] [Full Text] [PDF] G. Maskarinec, E. Erber, J. Gill, W. Cozen, and L. N. Kolonel Overweight and Obesity at Different Times in Life as Risk Factors for Non-Hodgkin's Lymphoma: The Multiethnic Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 196 - 203. [Abstract] [Full Text] [PDF]

	Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020